Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,514 | 25,561 | 41,819 | 116,564 | 39,387 |
| Marketable Securities | 54,125 | 89,166 | 15,048 | 3,175 | 70,155 |
| Receivables | 46 | 180 | 221 | 87 | 42,071 |
| Other current assets | 0 | 9 | 40 | 127 | 160 |
| TOTAL | $73,498 | $116,921 | $58,910 | $122,016 | $153,621 |
| Non-Current Assets | |||||
| PPE Net | 2,321 | 3,713 | 5,087 | 7,728 | 9,202 |
| Investments And Advances | 1,206 | 0 | 20,025 | 20,025 | 0 |
| Other Non-Current Assets | 967 | 1,965 | 3,432 | 5,601 | 6,693 |
| TOTAL | $4,494 | $5,678 | $28,544 | $33,354 | $15,895 |
| Total Assets | $77,992 | $122,599 | $87,454 | $155,370 | $169,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 833 | 11,817 | 2,025 | 4,050 | 3,691 |
| Accounts payable and accrued liabilities | 1,119 | 1,683 | 1,382 | 1,606 | 3,002 |
| Accrued Expenses | 5,372 | 5,935 | 7,174 | 8,558 | 7,466 |
| TOTAL | $7,324 | $20,186 | $22,877 | $26,448 | $26,393 |
| Non-Current Liabilities | |||||
| Long Term Debt | 152 | 985 | 2,615 | 4,639 | 7,144 |
| Deferred Revenues | N/A | 751 | 12,296 | 12,234 | 12,234 |
| TOTAL | $152 | $985 | $14,811 | $29,006 | $36,810 |
| Total Liabilities | $7,476 | $21,171 | $37,688 | $55,454 | $63,203 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,154 | 10,413 | 8,872 | 8,219 | 7,804 |
| Common Shares | 67 | 61 | 50 | 49 | 43 |
| Retained earnings | -360,650 | -311,363 | -335,907 | -279,533 | -230,639 |
| Other shareholders' equity | -4 | 1 | 18 | -330 | -1,169 |
| TOTAL | $70,516 | $101,428 | $49,766 | $99,916 | $106,313 |
| Total Liabilities And Equity | $77,992 | $122,599 | $87,454 | $155,370 | $169,516 |